β-catenin protein expression was upregulated in the AML cell line later than GSK-3β phosphorylation, indicating that Gal-3 stabilized β-catenin through GSK-3β phosphorylation in the hBM-MSCs-conditioned AML cell line. The gene discussed is GSK3B; the disease is acute myeloid leukemia.